Bioarctics forskningschef Johanna Fälting tar plats i VR:s ämnesråd

Bioarctics forskningschef Johanna Fälting och läkaren Markus Lingman har utsetts till nya ledamöter i Vetenskapsrådets ämnesråd för medicin och hälsa.

Fysikpriset till forskare inom maskininlärning

Årets Nobelpris i fysik går till John J Hopfield och Geoffrey E Hinton för deras insatser inom maskininlärning.

Innovative start-up helps doctors, scientists and industry balance coagulation risks

For many doctors caring for seriously ill patients, for example, in stroke units and cancer wards, maintaining the life-saving balance between bleeding and thro...

NorthX Biologics Matfors AB

Bayer has cut 1,500 roles – so far

German chemical and pharmaceutical group Bayer cut more than 1,500 roles in the first quarter alone– and most of them were management positions.

Samuel Lagercrantz: “Companies that do this successfully will take the lead”

The development of new medicines and medical technologies should not focus too narrowly on prolonging life. It is equally important to develop treatments that r...

Svag krona ingen nackdel för läkemedelsföretag

Läkemedels- och kemiföretag hör till vinnarna när den svenska kronan är svag, enligt en ny undersökning som bygger på intervjuer med representanter för företag.

RegFile AB

Tougher competition as the Novo Nordisk Foundation broadens its programme

Søren Nedergaard has worked with innovation at the Danish Government Offices and the University of Copenhagen. Today, he is COO of the Novo Nordisk Foundation, ...

Genterapi mot blödarsjuka visade effekt ännu efter fyra år

Den omtalade genterapin Hemgenix mot hemofili B visar god effekt fortfarande fyra år efter att behandlingen utförts.

SMC Corporation Appoints Bianca Brunell as New General Manager for the Nordic and Baltic Countries

SMC Corporation is pleased to announce the appointment of Bianca Brunell as the new General Manager for SMC’s Nordic and Baltic countries, effective June 1, 2024.

”Information security must become part of the Swedish life science strategy”

Sweden needs knowledge security to stand strong in the global competition, writes Björn Ursing in an opinion article.

Samuel Lagercrantz: ”Forskare, se upp för rovtidskrifter!”

”Precis som vi alla behöver vara vaksamma i vår vardag på vad som är sant och vad som är falskt, behöver forskare vara vaksamma på vilka tidskrifter de publicer...

Setback for pharmaceutical companies in the Zantac case

A Delaware judge has ruled in favour of allowing expert witnesses to testify in a case involving the now-cancelled drug Zantac and its potential carcinogenicity.

New issue of Life Science Sweden!

The international issue of Life Science Sweden has been sent to press.

Petter Hartman: Prioritera kommunikationen om forskning!

Vad fan får jag för pengarna? Forskning bör vara ett svar på den frågan, anser Petter Hartman.

Microscope and measuring machine in one

ZEISS O-INSPECT duo covers two essential applications in quality assurance.

Kvinnan bakom Novo Nordisks fetmasuccé: ”Slutade aldrig tro på GLP-1”

Det tog flera år av misslyckanden inom GLP-1 innan Lotte Bjerre Knudsen och hennes kollegor hittade rätt – men då var det en riktig fullträff. ”Vi investerade i...

Carl Borrebaeck – professor and serial entrepreneur with a taste for speed

Award-winning cancer researcher, the founder of many listed companies, and constantly in the academic and commercial spotlight for decades. However, Carl Borreb...

Isländsk genetikpionjär får Fernströms nordiska pris

En av världens mest kända forskare inom populationsgenetik, professor Kári Stefánsson från Island, tilldelas Eric K Fernström nordiska pris.

The life science strategy – what the industry wants

The process of updating the national life science strategy has begun at the government’s life science office. According to industry stakeholders, Sweden’s compe...

IVI’s Director General on establishing in Sweden: Will need up to 40 employees

The International Vaccine Institute, IVI, hopes to have its first staff on-site in Stockholm within a couple of months, says the institute’s Director General Je...

Total pipeline of pharmaceutical companies reaches a record high – 22,921 medicines are currently being developed

Despite the difficult economic times, pharmaceutical companies have never developed as many new drugs as now.

The Swedish Academy of Sciences: “We have too many researchers”

Sweden does not need more researchers, but it does need better ones. According to the Royal Swedish Academy of Sciences, funding should be distributed to favour excellence.